Susan C Price, MD
Geriatric Medicine · Honolulu
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Straub Clinic and Hospital · 420 clinicians in this group
Looking this up.
Hospitals listed: Straub Clinic and Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Price’s office at (808) 522-4000 to ask if they take your plan before you enroll.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 86.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Straub Clinic and HospitalHonolulu, HIAcute Care Hospital · Proprietary · Has an emergency departmentPart of Hawaii Pacific Health, which runs 4 hospitalsPatients rate it 4 of 5 · 75% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Postoperative respiratory failure rate: 16.47 (10.54 to 22.4) · 566 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.492, Oct 2024 – Sep 2025
See every measure and the patient survey for Straub Clinic and Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 2 better, 7 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative respiratory failure rateComplications and deaths | 16.47 (10.54 to 22.4) · 566 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.492 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 2.02 (1.05 to 3) · 795 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.17 (0.85 to 1.48) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 157.42 (109.15 to 205.69) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 70 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 140 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.3 · 234 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 314 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 157 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 2,463 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.36) · 3,593 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,831 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.34 (2.2 to 6.48) · 1,181 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0.11 to 3.11) · 520 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.79 (2.28 to 5.3) · 1,005 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.85 (1.27 to 8.42) · 530 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 197 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 1.11) · 3,199 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 52 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.416 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.63 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.359 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.502 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.5 · 270 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 11.2 · 172 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.8 · 261 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 6.2 · 314 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.2 · 561 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.4 to 7.1) · 256 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.1 (8.2 to 15) · 256 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 63 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 68 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 63 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.4 (11 to 18.8) · 1,140 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 630 cases | No different | Jan 2024 – Dec 2024 |
What patients said (482 patients answered, 31% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$15,746
Medicare paid this office $15,746 for 104 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 55 | $5,273 | $88 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 64 | $3,686 | $23 |
| New patient visit (60+ min) | 19 | $1,879 | $99 |
| Long return visit (40+ min) | 17 | $1,419 | $83 |
| Telephone medical discussion with physician, 11-20 minutes | 19 | $1,103 | $39 |
See all 6 services
| Long return visit (40+ min) | 55 | $5,273 | $88 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 64 | $3,686 | $23 |
| New patient visit (60+ min) | 19 | $1,879 | $99 |
| Long return visit (40+ min) | 17 | $1,419 | $83 |
| Telephone medical discussion with physician, 11-20 minutes | 19 | $1,103 | $39 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 56 | $746 | $13 |
Who their Medicare patients are
104 Original Medicare patients in 2024. Average age 87 · 85 and older 65% · Women 70% · Health risk score 1.43. At or below the middle of the specialty; the typical geriatric medicine clinician is at 1.84.
Conditions among them: High blood pressure 75% · Dementia 61% · Chronic kidney disease 55% · Diabetes 35% · Atrial fibrillation 30% · Coronary heart disease 26% · Depression 17% · Heart failure 15% · Stroke 13% · COPD 12%.
The office billed $54,170, Medicare allowed $25,567 and paid $15,746; for 373 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 104 | 373 | 87 | 1.43 | $54,170 | $15,746 |
| 2023 | 156 | 752 | 86 | 1.49 | $123,786 | $42,656 |
| 2022 | 159 | 764 | 86 | 1.59 | $147,313 | $51,161 |
| 2021 | 168 | 919 | 86 | 1.62 | $163,219 | $58,544 |
| 2020 | 142 | 524 | 85 | 1.72 | $114,783 | $44,970 |
| 2019 | 137 | 501 | 80 | 1.27 | $97,391 | $29,056 |
| 2018 | 66 | 168 | 79 | 0.99 | $35,206 | $12,381 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Long return visit (40+ min) | 118 | $19,749 | $101 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 122 | $8,344 | $23 |
| New patient visit (60+ min) | 43 | $5,473 | $127 |
| Telephone medical discussion with physician, 21-30 minutes | 39 | $4,459 | $71 |
| Telephone medical discussion with physician, 11-20 minutes | 35 | $2,121 | $43 |
| Advance care planning, first 30 minutes | 24 | $1,411 | $59 |
| Return visit (30+ min) | 14 | $1,098 | $69 |
2022: 7 services
| Long return visit (40+ min) | 119 | $22,029 | $114 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 112 | $8,348 | $26 |
| Telephone medical discussion with physician, 21-30 minutes | 50 | $7,114 | $73 |
| New patient visit (60+ min) | 47 | $6,976 | $148 |
| Advance care planning, first 30 minutes | 42 | $2,716 | $65 |
| Telephone medical discussion with physician, 11-20 minutes | 19 | $2,218 | $54 |
| Return visit (30+ min) | 17 | $1,491 | $71 |
2021: 8 services
| Long return visit (40+ min) | 103 | $23,195 | $100 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 111 | $10,215 | $26 |
| New patient visit (60+ min) | 70 | $9,364 | $134 |
| Telephone medical discussion with physician, 21-30 minutes | 41 | $6,793 | $81 |
| New patient visit (60+ min) | 12 | $2,100 | $175 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 15 | $1,718 | $28 |
| Advance care planning, first 30 minutes | 26 | $1,623 | $62 |
| Return visit (30+ min) | 17 | $1,202 | $63 |
2020: 9 services
| Long return visit (40+ min) | 78 | $11,118 | $85 |
| Extended office or other outpatient service, first hour | 53 | $5,877 | $100 |
| Return visit (30+ min) | 54 | $5,561 | $57 |
| Residence visit for established patient with high level of medical decision making, per day at least 60 minutes | 17 | $4,507 | $150 |
| New patient visit (60+ min) | 27 | $3,868 | $143 |
| Telephone medical discussion with physician, 21-30 minutes | 29 | $2,548 | $67 |
| Extended office or other outpatient service, first hour | 15 | $1,892 | $111 |
| Advance care planning, first 30 minutes | 27 | $1,809 | $67 |
| Telephone medical discussion with physician, 11-20 minutes | 18 | $868 | $41 |
2019: 5 services
| Long return visit (40+ min) | 96 | $11,662 | $59 |
| Return visit (30+ min) | 94 | $9,148 | $44 |
| New patient visit (60+ min) | 37 | $3,993 | $108 |
| Extended office or other outpatient service, first hour | 18 | $1,904 | $91 |
| Short return visit (20+ min) | 17 | $601 | $30 |
2018: 4 services
| Long return visit (40+ min) | 36 | $3,504 | $75 |
| Return visit (30+ min) | 36 | $3,499 | $56 |
| New patient visit (60+ min) | 16 | $2,000 | $125 |
| Extended office or other outpatient service, first hour | 17 | $1,581 | $88 |
Drugs they prescribed that Part D paid
$8,538
Pharmacies billed $8,538 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 399) in 2024. At or below the middle of the specialty; the typical geriatric medicine clinician is at 2%.
399 generic and 0 brand-name prescriptions · $8,538 in drug cost · 79 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mirtazapine | 80 | $3,632 | $45 |
| Memantine Hcl Er | 28 | $1,220 | $44 |
| Escitalopram | 51 | $906 | $18 |
| Donepezil | 50 | $677 | $14 |
| Quetiapine | 54 | $646 | $12 |
See all 9 drugs
| Mirtazapine | 80 | $3,632 | $45 |
| Memantine Hcl Er | 28 | $1,220 | $44 |
| Escitalopram | 51 | $906 | $18 |
| Donepezil | 50 | $677 | $14 |
| Quetiapine | 54 | $646 | $12 |
| Trazodone | 53 | $356 | $7 |
| Risperidone | 16 | $257 | $16 |
| Citalopram Hbr | 29 | $177 | $6 |
| Sertraline | 13 | $112 | $9 |
Year by year
| 2024 | 399 | 83 | 0% (0) | 0% | $8,538 |
| 2023 | 497 | 105 | None | None | $13,057 |
| 2022 | 617 | 124 | None | None | $21,382 |
| 2021 | 974 | 140 | 1% (14) | None | $75,413 |
| 2020 | 1,420 | 143 | 1% (12) | 15% | $112,725 |
| 2019 | 1,557 | 167 | 1% (21) | 15% | $97,164 |
| 2018 | 195 | 49 | None | 13% | $5,831 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Mirtazapine | 115 | $6,413 | $56 |
| Memantine Hcl Er | 18 | $2,164 | $120 |
| Donepezil | 40 | $902 | $23 |
| Trazodone | 80 | $574 | $7 |
| Escitalopram | 50 | $477 | $10 |
| Citalopram Hbr | 65 | $450 | $7 |
| Quetiapine | 51 | $353 | $7 |
| Olanzapine | 22 | $207 | $9 |
| Risperidone | 12 | $179 | $15 |
2022: 8 drugs
| Mirtazapine | 124 | $6,289 | $51 |
| Escitalopram | 86 | $455 | $5 |
| Donepezil | 30 | $422 | $14 |
| Citalopram Hbr | 65 | $372 | $6 |
| Olanzapine | 27 | $364 | $13 |
| Quetiapine | 49 | $350 | $7 |
| Trazodone | 55 | $251 | $5 |
| Risperidone | 13 | $172 | $13 |
2021: 25 drugs
| Januvia | 17 | $9,741 | $573 |
| Mirtazapine | 86 | $6,789 | $79 |
| Breo Ellipta | 11 | $4,096 | $372 |
| Atorvastatin | 48 | $724 | $15 |
| Levothyroxine | 22 | $527 | $24 |
| Potassium Chloride | 16 | $466 | $29 |
| Famotidine | 19 | $392 | $21 |
| Trazodone | 46 | $387 | $8 |
| Citalopram Hbr | 66 | $384 | $6 |
| Carvedilol | 21 | $382 | $18 |
| Omeprazole | 28 | $360 | $13 |
| Montelukast | 14 | $331 | $24 |
| Escitalopram | 60 | $288 | $5 |
| Sertraline | 22 | $281 | $13 |
| Metoprolol | 19 | $277 | $15 |
| Amlodipine Besylate | 36 | $276 | $8 |
| Metformin | 26 | $264 | $10 |
| Donepezil | 22 | $246 | $11 |
| Clopidogrel | 11 | $222 | $20 |
| Losartan | 23 | $196 | $9 |
| Quetiapine | 15 | $180 | $12 |
| Gabapentin | 16 | $106 | $7 |
| Oxycodone | 13 | $72 | $6 |
| Furosemide | 20 | $69 | $3 |
| Lisinopril | 15 | $50 | $3 |
2020: 34 drugs
| Eliquis | 19 | $11,281 | $594 |
| Jardiance | 13 | $7,274 | $560 |
| Mirtazapine | 69 | $3,487 | $51 |
| Rosuvastatin | 19 | $1,717 | $90 |
| Levothyroxine | 57 | $1,388 | $24 |
| Metoprolol | 43 | $1,371 | $32 |
| Atorvastatin | 79 | $1,216 | $15 |
| Celecoxib | 12 | $1,090 | $91 |
| Azelastine | 18 | $1,012 | $56 |
| Tamsulosin | 22 | $941 | $43 |
| Synthroid | 16 | $919 | $57 |
| Pregabalin | 15 | $668 | $45 |
| Omeprazole | 47 | $601 | $13 |
| Irbesartan | 21 | $592 | $28 |
| Potassium Chloride | 27 | $586 | $22 |
| Losartan | 64 | $498 | $8 |
| Gabapentin | 30 | $482 | $16 |
| Metformin | 50 | $441 | $9 |
| Trazodone | 28 | $389 | $14 |
| Amlodipine Besylate | 65 | $329 | $5 |
| Lovastatin | 19 | $304 | $16 |
| Montelukast | 17 | $275 | $16 |
| Famotidine | 18 | $272 | $15 |
| Clopidogrel | 14 | $245 | $18 |
| Lisinopril | 33 | $207 | $6 |
| Sertraline | 15 | $198 | $13 |
| Allopurinol | 16 | $181 | $11 |
| Furosemide | 36 | $145 | $4 |
| Citalopram Hbr | 24 | $136 | $6 |
| Escitalopram | 17 | $120 | $7 |
| Glipizide | 11 | $98 | $9 |
| Metoprolol | 14 | $80 | $6 |
| Simvastatin | 21 | $74 | $4 |
| Hydrochlorothiazide | 11 | $67 | $6 |
2019: 38 drugs
| Levothyroxine | 68 | $1,839 | $27 |
| Atorvastatin | 99 | $1,546 | $16 |
| Rosuvastatin | 17 | $1,502 | $88 |
| Metoprolol | 44 | $1,428 | $32 |
| Raloxifene | 11 | $1,289 | $117 |
| Azelastine | 25 | $1,268 | $51 |
| Duloxetine | 11 | $903 | $82 |
| Ventolin Hfa | 11 | $642 | $58 |
| Tamsulosin | 30 | $639 | $21 |
| Losartan | 75 | $560 | $7 |
| Metformin | 61 | $539 | $9 |
| Trazodone | 38 | $534 | $14 |
| Synthroid | 11 | $521 | $47 |
| Omeprazole | 26 | $487 | $19 |
| Amlodipine Besylate | 74 | $452 | $6 |
| Pantoprazole | 17 | $404 | $24 |
| Lovastatin | 17 | $383 | $23 |
| Gabapentin | 36 | $379 | $11 |
| Diltiazem 24hr Er (Cd) | 11 | $361 | $33 |
| Lisinopril | 49 | $344 | $7 |
| Sertraline | 19 | $334 | $18 |
| Ketoconazole | 14 | $273 | $20 |
| Mirtazapine | 16 | $244 | $15 |
| Simvastatin | 24 | $225 | $9 |
| Latanoprost | 17 | $214 | $13 |
| Furosemide | 44 | $191 | $4 |
| Metformin Hcl Er | 14 | $190 | $14 |
| Atenolol | 12 | $174 | $15 |
| Alendronate | 14 | $153 | $11 |
| Clopidogrel | 11 | $137 | $12 |
| Metoprolol | 19 | $125 | $7 |
| Escitalopram | 18 | $117 | $6 |
| Allopurinol | 14 | $113 | $8 |
| Fluoxetine | 13 | $94 | $7 |
| Hydrochlorothiazide | 11 | $62 | $6 |
| Azithromycin | 12 | $54 | $4 |
| Prednisone | 12 | $35 | $3 |
| Lorazepam | 12 | $23 | $2 |
2018: 2 drugs
| Levothyroxine | 12 | $199 | $17 |
| Furosemide | 11 | $29 | $3 |
Money from drug and device companies
$99 in 2024
| 2024 | 1 | 1 | None | $99 |
| 2021 | 1 | 1 | None | $27 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medline Industries LP | None | $99 | 1 payment
|
See the published payment
| Medline Industries LP | Meals · 2024-10-22 | None | $99 |
See earlier years (2021)
2021: $27
| Alnylam Pharmaceuticals | Onpattro | $27 | 1 payment
|
Professional record
- NPI
- 1851482517
- Licence
- HI MD9507
- Trained
- Saint Louis University School of Medicine, 1984
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 14690 Manuella Rd, Los Altos Hills, CA, 94022
- NPI first listed
- 2006-09-27
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.